PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Budelin Novolizer (budesonide) - Asthma
PAD Profile : Budelin Novolizer (budesonide) - Asthma
Keywords :
ICS, inhaled corticosteroids, respiratory, asthmatics
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Fostair NEXThaler (beclometasone and formoterol)
- Montelukast
- Theophylline
- Easyhaler (Salbutamol)
- Clenil Modulite (beclometasone)
- Easyhaler (Beclometasone)
- Easyhaler (Budesonide)
- Fostair (Beclometasone and formoterol)
- Dupilumab
- Airflusal (Salmeterol/Fluticasone) MDI
- Aerivio Spiromax (Fluticasone/Salmeterol) DPI
- Ventolin Accuhaler (salbutamol)
- Sereflo Ciphaler (Salmeterol / Fluticasone) DPI
- Campona Airmaster (Salmeterol / Fluticasone) DPI
- Salbutamol
- Terbutaline sulphate
- Budesonide
- Salamol Easi-Breathe
Other Indications
- Allergic rhinitis
- Asthma
- Inflammatory bowel disease
- Oesophagitis (inducing remission)
- Oesophagitis (maintenance)
- Covid-19
- Nephropathy
- Asthma
- Bronchopulmonary dysplasia
- Nasal polyps
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
01 February 2017
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
This product or device has not been included within the locally agreed list of preferred treatment options for Asthma. Please see Asthma Guidelines below.
There is no expectation for existing, stable patients to change drug or device unless this is agreed as a clinically appropriate course of action.
Prescribe inhaler devices by BRAND to ensure consistency and avoid confusion
Associated BNF Codes
03. Respiratory System
03.02.00. Corticosteroids (respiratory)